The University of Texas Health Science Center at San Antonio (UTHSCSA) has been awarded a $433,126 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 3-year research project to explore the role of the neuropeptide PACAP38 in post-traumatic headache, a common and debilitating condition affecting military personnel and veterans. The research aims to advance the understanding of the underlying biological mechanisms and develop potential therapeutic interventions. As a leading academic medical institution, UTHSCSA has significant expertise in biomedical research, particularly related to military and veteran health issues in South Texas. The grant represents part of the federal government's broader strategy to fund innovative medical research that addresses health challenges facing the U.S. armed forces.
Generated 1/28/25, 7:15 AM